4.4 Article

Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time

Anna R. Yousaf et al.

Summary: Improved understanding of the spectrum of SARS-CoV-2 infection is crucial for clinical and public health interventions. This study found that household contacts with confirmed SARS-CoV-2 infection reported mild symptoms, with some initially appearing asymptomatic but eventually developing symptoms over time. These findings are important for guiding infection control, contact tracing, and community mitigation strategies.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey

Kristina L. Bajema et al.

Summary: The study compared seroprevalence estimates from commercial laboratory residual sera and a community household survey in metropolitan Atlanta, finding the two estimates to be similar (4.94% vs 3.18%). Commercial sera can provide a rough measure of seroprevalence compared to more representative surveys.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Estimated Incidence of Coronavirus Disease 2019 (COVID-19) Illness and Hospitalization-United States, February-September 2020

Heather Reese et al.

Summary: The study estimated that the number of laboratory-confirmed cases in the United States during the COVID-19 pandemic was lower than the actual number, and provided preliminary estimates to indicate the societal and healthcare burdens. These estimates can help inform resource allocation and mitigation planning.

CLINICAL INFECTIOUS DISEASES (2021)

Editorial Material Medicine, General & Internal

Antibodies, Immunity, and COVID-19

Brad Spellberg et al.

JAMA INTERNAL MEDICINE (2021)

Article Medicine, General & Internal

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

Kristina L. Bajema et al.

Summary: This cross-sectional study indicates that as of September 2020, most people in the US did not have serologic evidence of previous SARS-CoV-2 infection, although the prevalence varied widely by jurisdiction. Seroprevalence surveys showed variations in infection rates between different sexes, age groups, and metropolitan/nonmetropolitan areas.

JAMA INTERNAL MEDICINE (2021)

Article Immunology

Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey

Jannae C. Parrott et al.

Summary: A population-based survey in New York City estimated SARS-CoV-2 antibody prevalence, revealing that by October 2020, nearly 1 in 3 black and Latino adults in NYC had antibodies. This highlights the unequal impacts of the COVID-19 pandemic on these communities.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Public, Environmental & Occupational Health

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019-COVID-NET, 14 States, March 1-30, 2020

Shikha Garg et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Review Medicine, General & Internal

Prevalence of Asymptomatic SARS-CoV-2 Infection A Narrative Review

Daniel P. Oran et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020

Fiona P. Havers et al.

JAMA INTERNAL MEDICINE (2020)

Article Public, Environmental & Occupational Health

Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020

Holly M. Biggs et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Article Public, Environmental & Occupational Health

Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020

Wesley H. Self et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Public, Environmental & Occupational Health

Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino - Denver, Colorado March-October 2020

Laura Jean Podewils et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Public, Environmental & Occupational Health

Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged

Charlotte V. Hobbs et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Public, Environmental & Occupational Health

COVID-19 Mitigation Behaviors by Age Group - United States, April-June 2020

Helena J. Hutchins et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Immunology

Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity

Hannah Clapham et al.

EMERGING INFECTIOUS DISEASES (2020)

Article Mathematical & Computational Biology

Construction of confidence limits about effect measures: A general approach

G. Y. Zou et al.

STATISTICS IN MEDICINE (2008)